Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$9.17 - $19.29 $842,723 - $1.77 Million
91,900 Added 314.73%
121,100 $1.34 Million
Q1 2023

May 15, 2023

BUY
$12.53 - $21.71 $362,117 - $627,419
28,900 Added 9633.33%
29,200 $392,000
Q4 2022

Feb 14, 2023

SELL
$11.61 - $16.11 $17,415 - $24,165
-1,500 Reduced 83.33%
300 $3,000
Q3 2022

Nov 14, 2022

SELL
$12.21 - $19.7 $709,401 - $1.14 Million
-58,100 Reduced 96.99%
1,800 $25,000
Q2 2022

Aug 15, 2022

BUY
$11.23 - $19.59 $612,035 - $1.07 Million
54,500 Added 1009.26%
59,900 $827,000
Q4 2020

Feb 16, 2021

SELL
$24.48 - $42.47 $146,880 - $254,820
-6,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$24.48 - $42.47 $132,192 - $229,338
5,400 New
5,400 $130,000
Q3 2020

Nov 13, 2020

BUY
$39.09 - $53.44 $152,451 - $208,416
3,900 Added 185.71%
6,000 $246,000
Q2 2020

Aug 14, 2020

SELL
$46.7 - $92.04 $1.37 Million - $2.71 Million
-29,400 Reduced 93.33%
2,100 $104,000
Q4 2018

Feb 14, 2019

BUY
$85.79 - $126.46 $2.14 Million - $3.16 Million
25,000 Added 384.62%
31,500 $3.18 Million
Q3 2018

Nov 14, 2018

SELL
$88.49 - $127.55 $3.85 Million - $5.55 Million
-43,500 Reduced 87.0%
6,500 $821,000
Q3 2017

Nov 14, 2017

BUY
$57.01 - $118.75 $2.85 Million - $5.94 Million
50,000
50,000 $2.9 Million

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.